Kenia - Englisch - Pharmacy and Poisons Board

flucloxacillin sodium - powder and solvent for oral solution - flucloxacillin 125 mg - flucloxacillin

Australien - Englisch - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - cloxacillin as the benzathine salt; brilliant blue fcf - misc. intra mammary - cloxacillin as the benzathine salt antibiotic active 600.0 mg/3.6gs; brilliant blue fcf dye-blue other 25.0 mg/3.6gs - antibiotic & related - dairy cattle | bovine | breeders | calves | dairy cow | growers | lactating cow | milking cow - corynebacterium spp. | mastitis | staphylococcus spp. | streptococcus spp. | bacterial canker | staphylococcosis | subclinical mastitis

Australien - Englisch - APVMA (Australian Pesticides and Veterinary Medicines Authority)

avet health limited - cloxacillin as the benzathine salt - misc. intra mammary - cloxacillin as the benzathine salt antibiotic active 166.7 mg/g - antibiotic & related - cow | bovine | female cattle - mastitis | subclinical mastitis

Australien - Englisch - APVMA (Australian Pesticides and Veterinary Medicines Authority)

norbrook laboratories australia pty limited - cloxacillin as the benzathine salt - misc. intra mammary - cloxacillin as the benzathine salt antibiotic active 600.0 mg/5.4gs - antibiotic & related - dairy cattle | bovine | breeders | calves | dairy cow | growers | lactating cow | milking cow - corynebacterium spp. | mastitis | organisms sensitive to cloxacillin | staphylococcus spp. | streptococcus spp. | bacterial canker | staphylococcosis | subclinical mastitis

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - flucloxacillin sodium monohydrate, quantity: 281.89 mg - capsule - excipient ingredients: methyl hydroxybenzoate; titanium dioxide; indigo carmine; gelatin; magnesium stearate; propyl hydroxybenzoate; purified water; propylene glycol; butan-1-ol; isopropyl alcohol; shellac; ethanol absolute; ammonia; potassium hydroxide - treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - flucloxacillin sodium monohydrate, quantity: 563.78 mg - capsule - excipient ingredients: indigo carmine; methyl hydroxybenzoate; propyl hydroxybenzoate; gelatin; magnesium stearate; titanium dioxide; purified water; propylene glycol; butan-1-ol; isopropyl alcohol; shellac; ethanol absolute; ammonia; potassium hydroxide - treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

a-s medication solutions - dicloxacillin sodium (unii: 4hzt2v9kx0) (dicloxacillin - unii:cof19h7wbk) - dicloxacillin 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules and other antibacterial drugs, dicloxacillin sodium capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. dicloxacillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. cultures and susceptibility tests should be performed initially to determine the causative organisms and their sensitivity to the drug (see clinical pharmacology – susceptibility  testing ). dicloxacillin may be used to initiate therapy in suspected cases of resistant staphylococcal infections prior to the availability of laboratory test results. the penicillinase-resistant penicillins should not be used in infections caused by organisms susceptible to penicillin g. if the susceptibility tests indicate that the infection is due to an organism other than a resistant staphylococcus, therapy should not be continued with a penicillinase-resistant penicillin. dicloxacillin sodium is contraindicated in persons who have shown hypersensitivity to any of the penicillins or any component of the formulations.

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

a-s medication solutions - dicloxacillin sodium (unii: 4hzt2v9kx0) (dicloxacillin - unii:cof19h7wbk) - dicloxacillin 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules usp and other antibacterial drugs, dicloxacillin sodium capsules usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. dicloxacillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. cultures and susceptibility tests should be performed initially to determine the causative organisms and their sensitivity to the drug (see clinical pharmacology – susceptibility plate testing ). dicloxacillin may be used to initiate therapy in suspected cases of resistant staphylococcal in

Israel - Englisch - Ministry of Health

a.l. medi-market ltd. - cloxacillin as sodium - powder for solution for inj/inf - cloxacillin as sodium 500 mg/vial - cloxacillin - cloxacillin is indicated for the treatment of sensitive staphylococcal infections:respiratory infections, otorhinolaryngologic infections, renal infections, urogenital infections, neuro-meningeal infections, bone and joint infections, endocarditis, and treatment of skin infections caused by sensitive staphylococci and/or streptococci.cloxacillin is also indicated as preventive treatment of postoperative infections in neurosurgery.

Israel - Englisch - Ministry of Health

a.l. medi-market ltd. - cloxacillin as sodium - powder for solution for inj/inf - cloxacillin as sodium 1000 mg/vial - cloxacillin - cloxacillin is indicated for the treatment of sensitive staphylococcal infections: respiratory infections, otorhinolaryngologic infections, renal infections, urogenital infections, neuro-meningeal infections, bone and joint infections, endocarditis, and treatment of skin infections caused by sensitive staphylococci and/or streptococci. cloxacillin is also indicated as preventive treatment of postoperative infections in neurosurgery.